Related Experiment Videos
Medication Safety Practice in Selected Saudi Hospitals: Alignment with the World Health Organization Global
Ghadah H Alshehri1, Layan S Alaqil2, Linah M Alghamdi3
1Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia.
Healthcare (Basel, Switzerland)
|June 26, 2026
Summary
Saudi hospitals primarily focused on medication systems and healthcare professionals to address the World Health Organization
Area of Science:
- Healthcare Management
- Patient Safety
- Clinical Pharmacy
Background:
- Saudi Arabia, like many nations, initiated programs to align with the World Health Organization's Global Medication Safety Challenge.
- This research investigates the specific strategies employed by Saudi hospitals to tackle medication safety concerns.
- The study was prompted by the WHO's Global Medication Safety Challenge and its adoption in Saudi Arabia.
Purpose of the Study:
- To assess the extent and nature of interventions implemented by Saudi hospitals.
- To evaluate how these interventions align with the World Health Organization's Medication Safety Challenge framework.
- To identify areas of focus and potential gaps in medication safety initiatives within Saudi healthcare settings.
Main Methods:
- A cross-sectional survey was administered to medication safety officers in Saudi secondary and tertiary care hospitals.
- Data collection occurred between January and June 2025, utilizing a survey adapted from existing tools.
- Interventions were categorized using the WHO Medication Safety Challenge framework, analyzed via descriptive and thematic methods.
Main Results:
- A total of 162 interventions were reported by 28 hospitals.
- The most common intervention domains were medication systems and practices (41.3%) and healthcare professionals (29%).
- Interventions predominantly targeted high-risk situations (81.4%) within the WHO priority areas.
Conclusions:
- Saudi hospitals have concentrated efforts on medication systems, professional practices, and managing high-risk scenarios.
- There is an opportunity to enhance medication safety by increasing focus on polypharmacy and patient engagement.
- Findings suggest a need for broader strategies to fully address the WHO Medication Safety Challenge in Saudi Arabia.
Related Concept Videos
Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
International Nursing Organizations II
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...